Martine A Rothblatt

Chairperson & CEO

Martine A Rothblatt (Chairperson & CEO) filed 169 Form 4 reports in the trailing twelve months (0 purchases, 169 sales, 2 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.9M of UTHR (18,840 sh across 15 lots, as filed), executed Apr 14.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

169

0 buys · 169 sells · 2 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$798.8M

shares × price, as filed

Last traded

Sep 18

Filed yesterday

Median ADV $265.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $823.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 168 filings

Sector per market data · by filing · past 12 months

Most traded names

UTHR

United Therapeutics Corporation UTHR · 0 buys · 174 sells 174 filings

Recent filings

UTHRSALE United Therapeutics Corporation View filing → $4.8M
9,117 sh across 13 lots
Exec Aug 11
Filed Aug 12 · 4:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.0M
9,380 sh across 13 lots
Exec Aug 10
Filed Aug 11 · 4:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.7M
8,877 sh across 11 lots
Exec Aug 7
Filed Aug 10 · 4:38 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.6M
8,838 sh across 12 lots
Exec Aug 6
Filed Aug 7 · 4:30 PM ET